Early airway infection, inflammation, and lung function in cystic fibrosis.
about
Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis.Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.Dysfunctional CFTR alters the bactericidal activity of human macrophages against Pseudomonas aeruginosa.Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.Correlation of forced oscillation technique in preschool children with cystic fibrosis with pulmonary inflammationIs limited computed tomography the future for imaging the lungs of children with cystic fibrosis?What and when to collect from infants with cystic fibrosisEarly detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume testsTarget concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic studyNew insights into pulmonary inflammation in cystic fibrosis.Endpoints for clinical trials in young children with cystic fibrosis.Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography.Association of lung function, chest radiographs and clinical features in infants with cystic fibrosisAssessment and monitoring of cystic fibrosis lung disease in infants and young children.Novel end points for clinical trials in young children with cystic fibrosisInterpretation of lung function in infants and young children with cystic fibrosis.What did we learn from two decades of chest computed tomography in cystic fibrosis?Respiratory syncytial virus pathophysiology and affect of palivizumab in special populations: cystic fibrosis and immunosuppression.Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis.Role of cytokine profile in the differential diagnosis between acute lung rejection and pulmonary infections after lung transplantation†.Narrowing in on early cystic fibrosis lung disease.Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.Early follow-up of lung disease in infants with cystic fibrosis using the raised volume rapid thoracic compression technique and computed tomography during quiet breathing.Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.Small airway deposition of dornase alfa during exacerbations in cystic fibrosis; a randomized controlled clinical trial.Ventilation inhomogeneities in relation to standard lung function in patients with cystic fibrosis.Infection is Not Required for Mucoinflammatory Lung Disease in CFTR-knockout Ferrets.Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments.Lung Function in Infants with Cystic Fibrosis Diagnosed by Newborn Screening
P2860
Q33298018-7CC1D6C3-ED30-4D0D-ABC5-F00B47BC42FEQ33310144-C103BD2F-8DE1-489C-85BF-E6687DCCABB6Q33916871-E6A62E3D-CB30-43EC-964E-C3D9D35EA359Q34118967-1C41B6BD-D403-4FEC-815D-293086ED7E1FQ35537438-CDEFB997-50A2-49E3-BB20-F046DDDBE847Q36152917-F7714FE5-9EDD-42BC-9CF9-2B0EBE9D2B95Q36154157-11CD94E9-0D48-4C59-9C4B-DB441E76BE98Q36166307-D378731C-226D-44C7-9005-92653746F722Q36536423-4462F2D8-8735-4E40-A856-299399E5B5ABQ36573117-4E78A004-54EE-404E-B835-7B5BBE96861BQ36891557-CE4EFEE4-1D1D-4D03-990B-1BB24DD4498AQ37144524-566DFDA5-8142-4979-9E86-6AFC3416BCB8Q37227977-A484298A-58CE-4C4A-8007-B33BBE904528Q37754879-A4FD0176-B3B0-4886-9650-5C35C8BFEB4DQ38111791-EF157D9E-354B-42F6-A8FF-D0CAF72A9C24Q38221780-5119AB62-1F28-4503-8A11-958E23BD380EQ38244028-FF23B329-4E72-46A2-B8C6-6DD8AA07652FQ38945689-A522664F-629C-4566-B0B0-6662F1E6B8E2Q40104046-E1EB7F9A-1B06-4BA4-AEC1-A812A09395ECQ41688914-8366AF8B-4088-48F6-A9CB-692E35CD3525Q44790185-A84A4C09-18A0-4235-9B5E-1301C7BF47CCQ45198841-F743DBEB-D488-48C8-AAC1-413DE9C11D40Q47786360-CC81C214-BE1A-4AFD-845C-6FE1909C6285Q47831284-93E66370-DE51-48F1-A992-2D7C40115125Q47861586-C31A29FF-5853-43BA-B9E1-87054AF085C2Q47899170-CACA8E66-9DFE-4FBB-A1DD-8465659C2CE9Q50070476-45442F8E-67B4-4BE7-A194-17825B1CBED8Q51651186-BA5CE7BC-77F5-4803-BC05-DF6B406449A6Q58385293-7829241D-4511-48EB-87F3-E9414A00DA47
P2860
Early airway infection, inflammation, and lung function in cystic fibrosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Early airway infection, inflammation, and lung function in cystic fibrosis.
@ast
Early airway infection, inflammation, and lung function in cystic fibrosis.
@en
type
label
Early airway infection, inflammation, and lung function in cystic fibrosis.
@ast
Early airway infection, inflammation, and lung function in cystic fibrosis.
@en
prefLabel
Early airway infection, inflammation, and lung function in cystic fibrosis.
@ast
Early airway infection, inflammation, and lung function in cystic fibrosis.
@en
P2093
P2860
P356
P1476
Early airway infection, inflammation, and lung function in cystic fibrosis
@en
P2093
C F Robertson
Claire Wainwright
D S Armstrong
K Grimwood
P2860
P304
P356
10.1136/ADC.87.4.306
P407
P577
2002-10-01T00:00:00Z